[go: up one dir, main page]

BR9708679A - Uso de indutores de pox, e, processo para tratamento auxiliar de pacientes submetidos à quimioterapia ou radioterapia. - Google Patents

Uso de indutores de pox, e, processo para tratamento auxiliar de pacientes submetidos à quimioterapia ou radioterapia.

Info

Publication number
BR9708679A
BR9708679A BR9708679-7A BR9708679A BR9708679A BR 9708679 A BR9708679 A BR 9708679A BR 9708679 A BR9708679 A BR 9708679A BR 9708679 A BR9708679 A BR 9708679A
Authority
BR
Brazil
Prior art keywords
radiotherapy
pox
auxiliary treatment
inducers
patients undergoing
Prior art date
Application number
BR9708679-7A
Other languages
English (en)
Inventor
Anton Mayr
Original Assignee
Anton Mayr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anton Mayr filed Critical Anton Mayr
Publication of BR9708679A publication Critical patent/BR9708679A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24211—Parapoxvirus, e.g. Orf virus
    • C12N2710/24232—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Control Of El Displays (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

"USO DE INDUTORES DE POX, E, PROCESSO PARA TRATAMENTO AUXILIAR DE PACIENTES SUBMETIDOS à QUIMIOTERAPIA OU RADIOTERAPIA". é divulgado o uso de indutores multipotentes de imunidade parapox, a partir de vírus não imunogênicos pox ou parapox (indutores de pox) atenuados, para produzir medicamentos com novas faixas de indicação na medicina humana.
BR9708679-7A 1996-04-15 1997-04-14 Uso de indutores de pox, e, processo para tratamento auxiliar de pacientes submetidos à quimioterapia ou radioterapia. BR9708679A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19614810 1996-04-15
PCT/DE1997/000761 WO1997038724A1 (de) 1996-04-15 1997-04-14 Neue indikationen für die verwendung von multipotenten paramunitätsinducern aus attenuierten, nicht-immunogenen pockenviren oder parapockenviren als arzneimittel

Publications (1)

Publication Number Publication Date
BR9708679A true BR9708679A (pt) 2000-01-04

Family

ID=7791302

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9708679-7A BR9708679A (pt) 1996-04-15 1997-04-14 Uso de indutores de pox, e, processo para tratamento auxiliar de pacientes submetidos à quimioterapia ou radioterapia.

Country Status (20)

Country Link
US (1) US6162600A (pt)
EP (1) EP0885013B1 (pt)
JP (1) JP3568208B2 (pt)
KR (1) KR100302994B1 (pt)
CN (1) CN1165343C (pt)
AT (1) ATE203678T1 (pt)
AU (1) AU706729B2 (pt)
BR (1) BR9708679A (pt)
CA (1) CA2251690C (pt)
DE (2) DE59704194D1 (pt)
DK (1) DK0885013T3 (pt)
ES (1) ES2125846T3 (pt)
GR (1) GR3037049T3 (pt)
HU (1) HU224308B1 (pt)
NO (1) NO322176B1 (pt)
NZ (1) NZ332243A (pt)
PL (1) PL329353A1 (pt)
PT (1) PT885013E (pt)
SI (1) SI0885013T1 (pt)
WO (1) WO1997038724A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1455674B (zh) * 2000-07-11 2019-03-29 艾库里斯有限及两合公司 绵羊副痘病毒菌株用于制备抗病毒药物和抗癌药物的用途
DE10122233A1 (de) * 2000-07-11 2002-01-24 Bayer Ag Verwendung von Stämmen des Parapoxvirus ovis gegen Organfibrosen
LU90996B1 (en) * 2000-07-11 2003-01-08 Bayer Ag Use of the strains of the parapox ovis virus against fibrosis
US6844000B2 (en) 2001-12-07 2005-01-18 Bayer Pharmaceuticals Corporation Use of Parapox B2L protein to treat cancer and modify immune responses
JP4897677B2 (ja) * 2004-07-13 2012-03-14 アイキュリス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング・ウント・コムパニー・コマンディットゲゼルシャフト Ｈｉｖ／ａｉｄｓの処置用の他の抗ウイルス剤と組み合わせたパラポックスウイルス
DE102004045758A1 (de) * 2004-09-21 2006-04-06 Toximed Gmbh Pharmazeutischer Wirkstoff gegen das HIV-Syndrom
DE102005027956B4 (de) * 2005-06-16 2009-10-22 Mayr, Anton, Prof. Dr. Dr. h.c. mult. Hochattenuierte Poxvirusstämme, Verfahren zu ihrer Herstellung und deren Verwendung als Paramunitätsinducer oder zur Herstellung von Vektor-Vakzinen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3504940C2 (de) * 1984-02-17 1997-11-06 Bayer Ag Multipotente Paramunitätsmediatoren, Verfahren zu ihrer Herstellung und diese Mediatoren enthaltende Arzneimittel
US6290962B1 (en) * 1992-11-03 2001-09-18 Oravax, Inc. Urease-based vaccine and treatment for helicobacter infection
DE4405841C1 (de) * 1994-02-23 1995-01-05 Mayr Anton Prof Dr Med Vet Dr Multipotente Paramunitätsinducer auf der Basis von Kombinationen von Pockenviruskomponenten, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

Also Published As

Publication number Publication date
AU706729B2 (en) 1999-06-24
WO1997038724A1 (de) 1997-10-23
DE19780300D2 (de) 1999-06-17
CA2251690A1 (en) 1997-10-23
HUP9901299A2 (hu) 1999-07-28
JP2000501114A (ja) 2000-02-02
EP0885013B1 (de) 2001-08-01
NO322176B1 (no) 2006-08-21
NZ332243A (en) 2000-10-27
HU224308B1 (hu) 2005-07-28
ES2125846T1 (es) 1999-03-16
CN1165343C (zh) 2004-09-08
CA2251690C (en) 2005-11-08
SI0885013T1 (pt) 2001-12-31
PT885013E (pt) 2002-01-30
AU2885897A (en) 1997-11-07
JP3568208B2 (ja) 2004-09-22
KR20000005479A (ko) 2000-01-25
DE59704194D1 (de) 2001-09-06
ES2125846T3 (es) 2001-12-16
ATE203678T1 (de) 2001-08-15
PL329353A1 (en) 1999-03-29
DK0885013T3 (da) 2001-11-05
CN1215996A (zh) 1999-05-05
NO984782L (no) 1998-12-15
KR100302994B1 (ko) 2001-11-30
GR3037049T3 (en) 2002-01-31
HUP9901299A3 (en) 2000-03-28
EP0885013A1 (de) 1998-12-23
NO984782D0 (no) 1998-10-14
US6162600A (en) 2000-12-19

Similar Documents

Publication Publication Date Title
WO2000052054A3 (en) Antibodies for cancer therapy and diagnosis
IL78553A (en) Therapeutic compositions of phosphonylmethoxyalkyl adenines
PT907365E (pt) Nova formulacao
BR9708679A (pt) Uso de indutores de pox, e, processo para tratamento auxiliar de pacientes submetidos à quimioterapia ou radioterapia.
EP0666985A1 (en) COMPRESSION TEST FOR EVALUATING A RESPIRATORY THERAPY DISEASE.
Olivera et al. Anxiety disorders coexisting with substance dependence: Treatment with buspirone.
Marsh et al. Psychosocial and vocational rehabilitation approaches to multiple sclerosis.
McCrady Implications for behavior therapy of the changing alcoholism health care delivery system.
FR2600256B1 (fr) Medicament et composition medicamenteuse pour le traitement des tumeurs ainsi que pour le traitement des maladies infectieuses dues aux virus
GEP20012377B (en) Use of Trophoblastic Beta-1 Glycoprotein for Treating Auto-Immune Diseases and Method of Treatment These Diseases
Freed Comments on Dr. Liptzin's paper: Erikson's theory from the perspective of women's life cycle.
Randoll et al. The role of complex biophysical—chemical therapies for cancer
ATE112489T1 (de) Extrakte von acanthospermum hispidum-pflanzen.
FR2645020B1 (fr) Medicament pour le traitement des maladies infectieuses dues aux retrovirus ainsi que pour le traitement des tumeurs
Lavaroni et al. Hallopeau's acrodermatitis treated with cyclosporin Aa case report
王小马 OBSERVATIONS OF THE THERAPEUTIC EFFECTS OF ACUPUNCTURE AND MOXlBUSTION IN 100 CASES OF DYSMENORRHEA
김현태 et al. A clinical and statistical study of submandibular stones
Court Canadian Abortion Rights Action League Inc. v. Attorney General of Nova Scotia, 13 October 1989
Reilly et al. Methadone Transition Treatment: A Treatment Model for 180-day Methadone Detoxification
NO954984L (no) Ny anvendelse av Ambasilide
Yoshimoto APPLICATION of MULTI-CHANNEL LOW POWER LASER to THE ACUPUNCTURE MEDICINE
MISHIMA et al. Treatment for Mental and Speech Disorder of Hemiplegic Patients
UCHIMOTO et al. Effect of Kampo Preparations on Nasal Allergy
Savage The Prevention and Control of the Rheumatic Diseases
GEU1999444Y (en) Medicinal Means “Barambo”

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
B09B Patent application refused [chapter 9.2 patent gazette]